MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$847,490
Net Income
$38,030
Net Profit Margin
4.49%
Unit: Dollar
Revenue Breakdown
Integrated Service Program
Allergy Diagnostic Kit Sales
Immunotherapy Treatment Sales
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
847,490
728,685
703,810
737,066
Cost of revenue
257,706
257,882
215,551
243,435
Gross profit
589,784
470,803
488,259
493,631
General and administrative
255,416
207,822
120,952
64,018
Sales and marketing
156,474
218,424
198,066
182,565
Research and development
114,621
120,909
115,707
132,769
Amortization
18,028
18,028
18,028
18,028
Total operating expenses
544,539
565,183
452,753
397,380
Net operating income (loss)
45,245
-94,380
35,506
96,251
Interest expense
7,215
9,526
42,519
62,840
Other income
-
-
20.5*
-
Gain on extinguishment of debt, net
-
-
589,128.25*
-
Loss on conversion of debt
-
-
25,562.75*
-
Income (loss) before income taxes
38,030
-103,906
556,573
-
Net income (loss)
38,030
-103,906
556,573
33,411
Basic EPS
0
0
0.049
0
Diluted EPS
0
0
0.029
0
Basic Average Shares
15,032,788
15,032,788
11,434,359
11,281,527
Diluted Average Shares
23,077,672
15,032,788
19,342,119*
19,326,411
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Integrated Service Program
$491,399
(86.40%↑ Y/Y)
Allergy Diagnostic Kit
Sales
$196,058
(-0.80%↓ Y/Y)
Immunotherapy Treatment Sales
$93,972
(-21.61%↓ Y/Y)
Clinical Study Revenue
$29,700
Training And Other
Revenue
$18,781
(279.72%↑ Y/Y)
Shipping And Handling
$10,914
(8.16%↑ Y/Y)
Subscription Revenue
$6,666
(-27.95%↓ Y/Y)
Revenue
$847,490
(39.98%↑ Y/Y)
Gross profit
$589,784
(47.81%↑ Y/Y)
Cost of revenue
$257,706
(24.84%↑ Y/Y)
Net operating
income (loss)
$45,245
(292.55%↑ Y/Y)
Total operating
expenses
$544,539
(40.53%↑ Y/Y)
Income (loss) before
income taxes
$38,030
(171.81%↑ Y/Y)
Interest expense
$7,215
(-88.81%↓ Y/Y)
General and
administrative
$255,416
(158.91%↑ Y/Y)
Sales and marketing
$156,474
(-1.25%↓ Y/Y)
Research and development
$114,621
(2.01%↑ Y/Y)
Amortization
$18,028
(0.00%↑ Y/Y)
Net income (loss)
$38,030
(171.81%↑ Y/Y)
Buy us a coffee
QHSLab, Inc. (USAQ)
QHSLab, Inc. (USAQ)